πŸ‡ΊπŸ‡Έ FDA
Patent

US 10265375

Ophthalmic compositions

granted A61KA61K31/355A61K31/436

Quick answer

US patent 10265375 (Ophthalmic compositions) held by AURINIA PHARMACEUTICALS INC. expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AURINIA PHARMACEUTICALS INC.
Grant date
Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/355, A61K31/436, A61K31/56, A61K38/13